tiprankstipranks
Trending News
More News >
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,779 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -2.97, suggesting Biogen is a Sell.
Biogen’s (BIIB) 20-Day exponential moving average is 121.98, while Biogen’s (BIIB) share price is $123.53, making it a Buy.
Biogen’s (BIIB) 50-Day exponential moving average is 129.43, while Biogen’s (BIIB) share price is $123.53, making it a Sell.

Biogen (BIIB) Pivot Points

May 03, 2025, 02:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
110.42
114.28
117.61
121.47
124.80
128.66
131.99
Fibonacci
114.28
117.03
118.73
121.47
124.22
125.92
128.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

May 03, 2025, 02:08 PM
Period
Simple
Exponential
MA5
120.97Buy
121.31Buy
MA10
119.67Buy
120.49Buy
MA20
118.61Buy
121.98Buy
MA50
132.03Sell
129.43Sell
MA100
139.21Sell
140.89Sell
MA200
165.07Sell
165.88Sell
Biogen’s (BIIB) 10-Day exponential moving average is 120.49, while Biogen’s (BIIB) share price is $123.53, making it a Buy.
Biogen’s (BIIB) 100-Day exponential moving average is 140.89, while Biogen’s (BIIB) share price is $123.53, making it a Sell.
Biogen’s (BIIB) stock price is $123.53 and Biogen’s (BIIB) 50-day simple moving average is 132.03, creating a Sell signal.
Biogen’s (BIIB) stock price is $123.53 and Biogen’s (BIIB) 100-day simple moving average is 139.21, creating a Sell signal.
Biogen’s (BIIB) stock price is $123.53 and Biogen’s (BIIB) 200-day simple moving average is 165.07, creating a Sell signal.

Biogen (BIIB) Technical Indicators

May 03, 2025, 02:08 PM
Name
Value
Implied Action
RSI (14)
49.54
Neutral
STOCH (9,6)
75.07
Neutral
STOCHRSI (14)
81.24
Sell
MACD (12,26)
-2.97
Sell
ADX (14)
26.34
Neutral
Williams %R
-16.95
Sell
CCI (14)
143.90
Sell
ATR (14)
4.32
-
Ultimate Oscillator
61.06
Neutral
ROC
7.26
Buy
Biogen’s (BIIB) Relative Strength Index (RSI) is 49.54, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 26.34, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is 143.90, creating a Sell signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is 7.26, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Hold.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 49.54, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -2.97, which suggests BIIB is a Sell.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 120.97, which suggests BIIB is a Buy.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 118.61, which suggests BIIB is a Buy.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 132.03, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 165.07, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -16.95, which suggests BIIB is a Sell.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is 143.90, which suggests BIIB is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis